Lilotomab
Lilotomab (HH1) is a murine anti-CD37 monoclonal antibody. Lilotomab reduces clonogenic survival. Lilotomab shows anti-tumor activity[1].
Product Specifications
CAS Number
[1453362-55-4]
Product Name Alternative
HH1
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lilotomab.html
Purity
98.99
Solubility
10 mM in DMSO
Smiles
[Lilotomab]
Molecular Weight
(145.24 kDa)
References & Citations
[1]Malenge MM, et al. 177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma. J Nucl Med. 2020 Oct;61 (10) :1468-1475.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H1999-02-01 2 µg
Hepatocellular Carcinoma, Recombinant, Human (Hemofiltrate Carcinoma Chemokine, HCC-1) discontinued
Ask
View Details H1999-02-02 10 µg
Hepatocellular Carcinoma, Recombinant, Human (Hemofiltrate Carcinoma Chemokine, HCC-1) discontinued
Ask
View Details